Companies / Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc.
Nasdaq: EWTXCIK 1710072BOULDER, CO
Financials
Ownership
108.6M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 0.05% | 53,592 |
| Institutions | 114.06% | 123,879,074 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Fox Jonathan CDirector | 0.02% | 24,175 |
Edris BadreddinDirector | 0.02% | 19,820 |
| <0.01% | 9,597 | |
Brege LauraDirector | — | — |
Morris ArleneDirector | — | — |
Thompson Peter A.Director · 10% owner | — | — |
Institutional holders 204
View all →| Holder | Value | % of shares |
|---|---|---|
| $488.83M | 14.29% | |
| $328.50M | 9.60% | |
| $268.42M | 6.08% | |
| $207.14M | 6.05% | |
| $186.29M | 5.45% | |
| $168.53M | 4.93% | |
| $162.32M | 6.02% | |
| $139.36M | 4.07% | |
| $129.31M | 4.80% | |
| $120.89M | 4.49% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $1.96M | -66K -77.03% | 19,820 0.02% of shares | medium |
| Mar 31, 2026 | Donovan Joanne M. Executive | Sell | Common Stock | $685.3K | -21K -68.98% | 9,597 <0.01% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $507.4K | -17K -14.17% | 104,365 0.10% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $403.0K | -14K -10.12% | 121,601 0.11% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $308.0K | -10K -10.81% | 86,297 0.08% of shares | medium |
| Mar 27, 2026 | Donovan Joanne M. Executive | Sell | Common Stock | $298.1K | -10K -37.08% | 16,332 0.02% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $223.9K | -8K -7.29% | 96,760 0.09% of shares | medium |
| Mar 27, 2026 | Donovan Joanne M. Executive | Sell | Common Stock | $208.6K | -7K -41.24% | 9,597 <0.01% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Paradigm BioCapital Advisors LP | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EWTX | — | 28036F105 |